DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Andreone P, Colombo MG, Enejosa JV. , et al.
ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.
Gastroenterology 2014;
147 (02) 359.e1-365.e1
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.